Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs397507444
rs397507444
0.010 GeneticVariation BEFREE MTHFR 1298A>C genotype remained a significant predictor in a multivariate analysis including metastasis characteristics. 15608557

2004

dbSNP: rs761872690
rs761872690
0.010 GeneticVariation BEFREE We conclude that the GNB3 825C>T polymorphism does not appear to be associated with breast cancer risk, but may influence development of metastasis in low-grade tumors. 15019160

2004

dbSNP: rs765431049
rs765431049
0.010 GeneticVariation BEFREE To directly assess its role in tumor growth and metastasis in vivo, we stably transfected HT-1080 fibrosarcoma cells expressing either fully active wild-type human TFPI-2 (WT) or inactive R24Q TFPI-2 (QT) and examined their ability to form tumors and metastasize in athymic mice in comparison to mock-transfected cells (MT). 14525759

2004

dbSNP: rs113488022
rs113488022
0.100 GeneticVariation BEFREE Unexpectedly, V599 and V599E mutations were absent in cutaneous/subcutaneous metastases derived from acrolentiginous melanomas as preceding primary tumours. 15935100

2005

dbSNP: rs113488022
rs113488022
0.100 GeneticVariation BEFREE In line with the previous reports, NRAS/BRAF mutations were rare; only one metastatic tumor had an NRAS E61R mutation, and one primary tumor and two metastases harbored BRAF V599E mutations. 16098043

2005

dbSNP: rs113488022
rs113488022
0.100 GeneticVariation BEFREE Sixty-eight samples (20 of 36 primaries, 18 of 27 regional metastases, 16 of 40 nodal metastases, and 9 of 12 distant metastases) harbored the V599E B-RAF mutation (59%), 17 contained a Q61R N-RAS mutation, and 4 contained a Q61K N-RAS mutation. 15737846

2005

dbSNP: rs121913377
rs121913377
0.100 GeneticVariation BEFREE Sixty-eight samples (20 of 36 primaries, 18 of 27 regional metastases, 16 of 40 nodal metastases, and 9 of 12 distant metastases) harbored the V599E B-RAF mutation (59%), 17 contained a Q61R N-RAS mutation, and 4 contained a Q61K N-RAS mutation. 15737846

2005

dbSNP: rs121913377
rs121913377
0.100 GeneticVariation BEFREE Unexpectedly, V599 and V599E mutations were absent in cutaneous/subcutaneous metastases derived from acrolentiginous melanomas as preceding primary tumours. 15935100

2005

dbSNP: rs121913377
rs121913377
0.100 GeneticVariation BEFREE In line with the previous reports, NRAS/BRAF mutations were rare; only one metastatic tumor had an NRAS E61R mutation, and one primary tumor and two metastases harbored BRAF V599E mutations. 16098043

2005

dbSNP: rs121913227
rs121913227
0.080 GeneticVariation BEFREE The oncogenic B-raf mutations V599E and V599K, as early events in melanocyte transformation, persist throughout metastasis with important prognostic implications. 16179870

2005

dbSNP: rs121913227
rs121913227
0.080 GeneticVariation BEFREE As to the B-raf protein sequence, the acidic amino acid transitions V599E and V599K were predicted in 19/60 (32%) and 6/60 (10%) cases, respectively, but were not associated with enhanced risk for subsequent metastasis in patients' follow up. 15935100

2005

dbSNP: rs1057519824
rs1057519824
MET
0.020 GeneticVariation BEFREE The Y1235D mutation identified in metastases was shown to induce constitutive activation and a motile-invasive phenotype on transduced carcinoma cells. 16245927

2005

dbSNP: rs11549465
rs11549465
0.020 GeneticVariation BEFREE The Pro582Ser change in HIF-1alpha was detected in six patients (11%) and was positively correlated with the development of metastases (P=0.023). 15809750

2005

dbSNP: rs17576
rs17576
0.020 GeneticVariation BEFREE These findings indicate that the potentially functional polymorphisms, MMP-9 P574R and R279Q, may confer the biomarker in the occurrence and metastasis of primary lung cancer. 16061858

2005

dbSNP: rs17577
rs17577
0.020 GeneticVariation BEFREE To test our hypothesis that common nonsynonymous SNPs, R279Q, P574R, and R668Q, in MMP-9 are associated with lung cancer development and metastasis, we conducted a case-control study of 744 patients with incident lung cancer and 747 cancer-free controls in Southeast China. 16061858

2005

dbSNP: rs2250889
rs2250889
0.020 GeneticVariation BEFREE When we examined the combined effect of R279Q and P574R and used the 279R and 574P as the risk alleles, a significantly increased risk of lung cancer was associated with both the genotypes containing "1 to 2 risk alleles" (adjusted OR, 2.16; 95% CI, 1.30-3.59) and containing ">2 risk alleles" (adjusted OR, 2.44; 95% CI, 1.48-4.03), and it was more pronounced in 290 lung cancer cases with metastasis [adjusted OR, 2.30 (95% CI, 1.09-4.85) for the 1 to 2 risk alleles subgroup and adjusted OR, 2.82 (95% CI, 1.35-5.88) for the >2 risk alleles subgroup], compared with those without any risk alleles. 16061858

2005

dbSNP: rs5443
rs5443
0.020 GeneticVariation BEFREE There was no association of GNB3 C825T genotype with tumor stage or grade, but follow-up analysis in the subgroup of non-smokers revealed a shorter time to metastasis in 825T-allele carriers compared to individuals homozygous CC. 16133558

2005

dbSNP: rs34296044
rs34296044
0.010 GeneticVariation BEFREE We investigated the relationship of single nucleotide polymorphisms (SNPs) at exon 10 (T439M) and exon 13 (P757L) of the EXO1 gene with development, progression and metastasis of colorectal cancer. 15550454

2005

dbSNP: rs3732379
rs3732379
0.010 GeneticVariation BEFREE The V249I polymorphism revealed no association with tumor grade and stage, the presence of extrahepatic metastasis or the degree of fibrosis in non-tumorous tissue. 15809764

2005

dbSNP: rs4149963
rs4149963
0.010 GeneticVariation BEFREE We investigated the relationship of single nucleotide polymorphisms (SNPs) at exon 10 (T439M) and exon 13 (P757L) of the EXO1 gene with development, progression and metastasis of colorectal cancer. 15550454

2005

dbSNP: rs486907
rs486907
0.010 GeneticVariation BEFREE In familial pancreatic cancer, however, patients with Arg462Gln variants had more aggressive tumors with more high grade cancers (OR = 15.40, p = 0.009) and more distant metastases (OR = 7.00, p = 0.04) than patients with the wild-type genotype. 15981205

2005

dbSNP: rs9350
rs9350
0.010 GeneticVariation BEFREE We investigated the relationship of single nucleotide polymorphisms (SNPs) at exon 10 (T439M) and exon 13 (P757L) of the EXO1 gene with development, progression and metastasis of colorectal cancer. 15550454

2005

dbSNP: rs113488022
rs113488022
0.100 GeneticVariation BEFREE BRAF(V600E) significantly correlated with absence of node metastasis. 16452550

2006

dbSNP: rs113488022
rs113488022
0.100 GeneticVariation BEFREE In summary, this study provides a mechanistic basis for targeting Mek and not B-Raf in the mutant (V600E)B-Raf signaling cascade to inhibit melanoma metastases. 16912199

2006

dbSNP: rs121913377
rs121913377
0.100 GeneticVariation BEFREE BRAF(V600E) significantly correlated with absence of node metastasis. 16452550

2006